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ABSTRACT  
Objective: This study aims to determine the antiemetic potential of stingless bee propolis in reducing the prevalence of nausea due to consumption 
of Anti-Tuberculosis Drugs (ATD) in Tuberculosis patients and to identify phytochemical compounds that act as an antiemetic in propolis. 
Methods: The stingless bee propolis used was Wallacetrigona incisa from South Sulawesi. The clinical testing used the randomized controlled trial, 
randomization using permuted block randomization consisting of one positive control group and two treatment groups. The active components 
analyzed using Gas Chromatography-Mass Spectrometer (GC-MS) pyrolyzer.  
Results: This study found that the measurement at week 0 obtained the mean value of nausea per week for each group P0 (Placebo), P1 (Propolis 
6%), and P2 (Propolis 30%) were respectively 2.14; 1.5 and 5.2 events/week, at week 8 the prevalence of nausea by 2.0; 1.0; and 1.6 events/week, 
and week 24 the prevalence of nausea by 3.0; 0; and 0 events/week. There are 11 compounds with concentrations above 1% that act as antiemetic 
compounds either through direct and indirect mechanism with a total concentration reaches 75,47%.  
Conclusion: Based on all determinant parameters, propolis of Wallacetrigona incisa species from South Sulawesi has antiemetic activity and can 
reduce the prevalence of emetic induced by ATD consumption in pulmonary TB patients.  
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INTRODUCTION 
Pulmonary tuberculosis (TB) is an infectious pulmonary disease that is 
still prevalent in Indonesia. In 2018, 570.289 pulmonary TB cases were 
recorded and treated in Indonesia, with an estimated mortality index of 
12% [1]. Infection of pulmonary TB is caused by Mycobacterium 
tuberculosis (MTB), is a pathogenic bacteria that can live and multiply 
inside and outside phagocytic cells so that the process of forming a 
bacterial colony is difficult to control and resist [2]. 
TB control in Indonesia started in 2000 by implementing the DOTS 
(Directly Observed Treatment Short-course) strategy. This strategy is 
a treatment step using anti-TB drugs (ATD), which consists of a 
combination of several types of drugs that are effective in treating 
TB [3]. Combining ATD is considered effective but has side effects, 
such as nausea, vomiting, and appetite loss [4]. The effects will 
decrease a patient’s nutritional intake and worsen the patient’s 
nutritional status, which causes a longer recovery process [5]. The 
condition of nausea and vomiting can be minimized by 
administering an antiemetic compound (anti-nausea) and one of the 
products proven to have antiemetic properties is propolis [6, 7].  
Propolis is a resin that is produced by bees and used as a hives 
building material. Propolis is formed from plant origin collected and 
processed by bees with the addition of various natural enzymes and 
saliva in their bodies [8]. Stingless bees produce propolis as a form 
of self-defense so that it produces more propolis than other species. 
Stingless bees propolis also has a high flavonoid content which made 
bees of this species more widely cultivated as propolis producers [9, 
10]. Phytochemical compounds in the form of flavonoids and 
phenolics in propolis can play an active role as antioxidants, 
antimicrobials, antiseptics, and antiemetic [6, 11, 12]. 
The study on the benefits of propolis as antiemetic is still minimal, 
but Fikri et al. [6] conducted an antiemetic test of Indonesian 
propolis on chicks given CuSO4 and reported that Indonesian 
propolis reduced symptoms of nausea and has a similar effect with 
antiemetic power of metoclopramide (an anti-nausea drug). Induction 
of CuSO4 in chicks will stimulate the irritated stomach wall that causes 
nausea and vomiting mechanisms. These mechanisms also occur in 
humans so that they are suitable for modeling the potential antiemetic 
of a compound or product [13]. The finding triggered to develop 
propolis as an antiemetic for humans, Sulaeman et al., which states 
that propolis has the potential to reduce nausea and vomiting in 
pregnancy [11]. Therefore, this study is important to determine the 
antiemetic potential of stingless bee propolis in reducing the 
prevalence of nausea due to consumption of ATD in TB patients and to 
identify phytochemical compounds antiemetic in propolis. 
MATERIALS AND METHODS 
Materials  
The material used in this study was propolis originating from South 
Sulawesi in stingless bees Wallacetrigona incisa which was 
harvested by a group of farmers and obtained through the 
intermediary CV. Nutrima Sehatalami, Bogor. The use of these 
samples is based on the active compound, IC50, and the propolis’s 
toxicity has the best cumulative index value among other propolis in 
Indonesia [11, 12]. 
Propolis extraction 
The method of extraction propolis was from patent no. 
P00201100811 in 2011 about short, productive, and efficient 
extraction method in the production of liquid propolis. 
First, 1 kg raw propolis (still in the glass transition process) was cut 
to a smaller size, then mixed with 70% ethanol with a ratio 1: 2,5 
(propolis: ethanol). This process was carried out at room 
temperature to avoid damage to propolis due to high temperatures. 
Then, propolis was mashed into propolis pulp and filtered using a 
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30-mesh filter before being left for 12 h. The filtrate was separated 
while the rest of the propolis pulp was mixed with ethanol 70% at a 
ratio of 1: 1,5 (propolis: ethanol) and was mixing for 5 min. 
The next step was the evaporation of filtrate using a rotary vacuum 
evaporator connected to a vacuum pump with a pressure 4 kPa, 
rotation pump 3 rpm, at 50 °C. When the ethanol had evaporated 
out, the filtrate colours turned into light-brown and turned into 
dark-brown until the remaining water had evaporated. The result of 
this filtrate was a dark-brown extract of propolis. After that, the 
propolis extract was added with propylene glycol and was filtered 
using Whatman paper no. 50.  
Clinical testing 
The design used was a randomized controlled trial, randomization 
using permuted block randomization [14], consisting of one positive 
control group and two treatment groups. Intervention and testing 
were carried out in a double-blind manner (both the investigator 
and the subjects were unaware of the treatment given). The subject 
size was determined according to the sample size table in a 
controlled clinical trial [15]. Based on the table, assuming a 
significance level of α 0.05 and a power of 80%, the minimum 
sample size is 13 subjects per group. The samples used 50 subjects 
to ensure data security and validity. 
The criteria for the research subjects were as follows: a) Inclusion 
criteria: TB patients, aged 12-45 y (adolescents-adults), willing to 
participate in the study by signing informed consent; b) Exclusion 
criteria: smoking, suffering from hepatitis or other diseases that 
interfere with the study, drinking alcohol, pregnant, breastfeeding, 
using contraceptives, taking other drugs or herbs or supplements, 
and TB patients recurring.  
The propolis dose in the subject was carried out with an approach as 
a companion drug for ATD. The positive control group was given a 
companion in the form of propylene glycol liquid placebo. The dose 
determination of treatment group one was based on the clinical dose 
of Pranandaru et al. (2011), were 3 drops of propolis (20% 
concentration) in TB patients, the dose given for group one was 
twice from the reference dose by administering 20 drops of propolis 
(6% concentration) [16],. The dose given for group two was 30 
drops of propolis (30% concentration), was equivalent to five times 
the dose for group one and was still lower than the clinical dose of 
Liu et al. (2013), 103,2 drops of propolis. This method used an 
equalization of the number of propolis droplets of 20 drops in one 
use; one drop of propolis was equivalent to 0,028 ml assuming a 6 
ml volume eye drop bottle (20 drops ≈ 0.56 ml) [17]. The propolis 
had given every day for 56 d (2 mo early in the intensive phase of 
pulmonary TB treatment with ATD, then follow-up control was 
carried out of given propolis 3 times a week for 16 w (the next stage 
of pulmonary TB treatment with ATD). 
The incidence of nausea was observed for 6 mo with data retrieval 3 
times, namely during the first week of initial intervention (W0), the 
intensive transition period to the advanced stage (W8), and the last 
week of intervention (W24). 
All clinical experiments were carried out under ethical approval 
from the Health Research Ethics Committee, Faculty of Medicine of 
University of Indonesia number: 1036/UN2. F1/ETIK/2015. 
GCMS (Gas Chromatography Mass Spectrometry) analysis  
This study used Shimadzu GCMS-QP 2010 with pyrolysis, with the 
carrier gas is in the form of Helium UHP, rt x 5 ms column. The 
column oven temperature was set to 50 °C for 5 min, then gradually 
increase to 280 °C. The temperature injection pressure was set at 
101 kPA with column flow 0,85 ml/min. MS detector was set at ion 
source temperature (200 °C), interface temperature 280 °C, detector 
temperature 280 °C, pyrolyzer temperature 300 °C. When stable, 1 
µg/1 drop liquid propolis was injected into the pyrolyzer, and GC-MS 
worked automatically. The process of determination took 50 min, 
and the results of chromatogram were stored on a computer. The 
active compounds of propolis were identified using the Willey 
standard and Nist Libraries on GCMS data system.  
Phytochemical screening 
Phytochemical screening was to examine the active compounds of 
propolis which acts as antiemetic. The chromatogram from the GC-
MS pyrolysis results contains information about active compounds of 
propolis sample. Furthermore, a literature study was carried out to 
find the biological activity or mechanism of each active compound’s 
action, from in vitro, in vivo, and clinical research. The GC-MS 
chromatogram was compared to literature studies to find every 
active compound of propolis that could reduce the prevalence of 
nausea during ATD consumption. 
RESULTS AND DISCUSSION 
Effects of propolis on the prevalence of nausea  
Nausea is a symptom that can be used as an indication or response 
to the presence of toxic compounds that enter the body [18, 19]. The 
sensation of nausea can be suppressed or eliminated through 
phytochemical compounds with antiemetic activity [13]. As an ATD 
companion, performed to reduce nausea and vomiting symptoms 
due to side effects of pulmonary TB treatment using ATD. The 
results of the measurement of the average prevalence of nausea are 
presented in fig. 1. 
 
 
Fig. 1: Changes in average prevalence of nausea 
Based on the results of the graph in fig. 1., the measurement at week 
0 obtained the mean value of nausea per week for each group P0, P1, 
and P2 were respectively 2.14; 1.5 and 5.2 events/week. Variation of 
data on P2 value has the highest number compared to other groups, 
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the difference in data is considered normal. The grouping of 
research subjects has been carried out evenly by using permuted 
block randomization methods based on the sex and age of the patient 
so that the response that appears has a low level of bias for 
confounding variables [15, 20].  
Measurement of the 8th week of all treatment groups decreased the 
prevalence of nausea by 0.14; 0.5; and 3.6 events/week for groups 
P0, P1 and P2. Based on these data, the P2 group until the end of the 
intervention (propolis supplementation), namely at week 24th 
showed the greatest decrease until it reached a value of 0 incidents 
of nausea/week, followed by group P1, which also experienced a 
decrease to a value of 0 incidents of nausea/week, while the group 
P0 has increased the prevalence of nausea/week.  
The increase in the prevalence of nausea in the P0 group is an 
indication of the presence of toxic compounds from ATD that 
accumulate in the digestive tract, plasma, and even Cerebrospinal 
fluid (CSF) [18, 19, 21]. These toxic compounds come from the 
consumption of ATD, first-line ATD (Isoniazid, Rifampicin, 
Pyrazinamide, and Ethambutol) are cytotoxic drugs; these 
properties are needed to destroy MTB cell [22, 23]. Its presence in 
the body as a toxic compound often causes side effects such as 
nausea, vomiting, indigestion, and others [22, 24].  
This can be severe due to allegations of liver injury resulting from 
the consumption of hepatotoxic ATD [25]. Consumption of ATD for a 
long time will cause the accumulation of toxic compounds resulting 
in chronic toxicity conditions and lead to liver injury [21]. Liver 
injury will have an impact on the reduction of liver function as a 
detoxifying organ and will cause symptoms of nausea and vomiting 
if exposed to toxic compounds and accumulation of toxic compounds 
[19, 21, 26, 27]. Isoniazid, rifampicin and pyrazinamide are 
hepatotoxic drugs, the metabolism of these compounds is carried 
out in the liver with the help of the body's natural enzymes [22].  
Isoniazid is the most toxic drug in the first-line ATD, because isoniazid 
is a toxic compound both from its function as a radical compound that 
destroy Tb cells and in terms of its intermediate metabolites which are 
more toxic and capable of damaging liver cells [22, 24, 26]. Rifampicin 
is a toxic compound that is easily detoxified by the liver, but when 
combined with isoniazid, rifampicin will cause an increase in the level 
of toxicity to the liver [22, 23, 26]. Meanwhile, pyrazinamide is the 
most hepatotoxic drug because of its use, it causes more symptoms of 
liver damage than other drugs, and it is even recommended to be 
replaced by a combination of first-line ATD [28].  
The phenomenon of increasing the prevalence of nausea caused by 
liver damage has attracted the attention of researchers because apart 
from having antiemetic activity, Indonesian propolis also function as a 
hepatoprotector. The active compounds in propolis are able to protect 
the liver from the toxic effects of ATD [11, 29]. Therefore, liver damage 
can be anticipated, so that the function of the liver as a detoxification 
organ is not disturbed and the incidence of emesis can decrease.  
The final results of the observation group P1 and P2 experienced a 
decrease when compared to before the intervention, the value of the 
decrease was 1.5 and 5.2 incidents of the nausea/week, while the P0 
group experienced an increase of 0.86 incidents of the nausea/week. 
Thus,the P2 group experienced the greatest decrease in the 
prevalence of nausea and vice versa, the P0 group experienced an 
increase in the prevalence of nausea. This shows that the treatment 
of propolis supplementation with a concentration of 6% (P1) and 
30% (P2) against TB patients who consume ATD has an antiemetic 
effect. 
Antiemetic compounds propolis wallacetrigona incisa from 
south sulawesi 
Identification of the active compound of ATD complementary 
propolis was carried out using the GCMS pyrolysis and found about 
100 constituent compounds. These compounds are phytochemical 
compounds which are derivatives of polysaccharide compounds, 
lipopolysaccharides and amino polysaccharides. The identification of 
active antiemetic compounds will only be carried out on compounds 
with concentrations above 1%, with the consideration that the 
consumption of propolis as a complement to ATD is only 20 drops 
(equivalent to 0.56 ml) so that the concentration is considered too 
low. In addition, compounds with a concentration of<1% have not 
much known biological activity, although there is a possibility that 
they may have a direct antiemetic activity or a synergistic 
relationship with other compounds.  
There are 16 compounds with concentrations above 1% with a total 
concentration of 84.46%. The list of active compounds along with 
their concentrations and biological activities, are shown in detail in 
table 1. The function of these compounds has been further identified, 
especially their role as antiemetic by the literature study method. 
The functions of these compounds were investigated, especially as 
an anti-emetic by means of literature studies. Based on the results of 
the literature study, it was found that 16 compounds had a 
concentration of>1%, and as many as 11 compounds had antiemetic 
activity either directly or indirectly, 1 compound had biological 
activity other than antiemetic and 3 compounds had no biological 
activity. Compounds that have antiemetic activity include: (1) 
Methyl-α-d-glucopyranoside, (2) 5-Azulenemethanol, 1,2,3,3a, 4,5,6,7-
octahydro-alpha. alpha, 3, 8-tetramethyl, (3) 1,2,3-Propanetriol, (4) 
Hexadecanoic acid, (5) Ethyl Ester 3-Hydroxy-Tridecanoic Acid, (6) 
2,6-Dimethoxyphenol, (7) Pentadecanoic acid, 14-methyl-, methyl 
ester, (8) 1,6-Anhydro-Beta-D-Glucopyranose, (9) (2S, 3R)-3-Allyl-3-
methylapfelsaure-4-ethylester, (10) 1,4, 5-Trimethylnaphthalene, (11) 
Tetradecanoic acid. Compounds that have biological activity are: 
Isosorbide. Meanwhile, 3 compounds that have not been found with 
biological activity are: (1) 2-Methoxyethyl acetate, (2) 8-Oxabicyclo 
[5.1.0] octane, (3) Dimethyl 2-hydroxy-2-methylbutane-1,4-dioate. 
The remaining 86 compounds had a concentration of<1% with an 
accumulated concentration of 15.54%. The amount of accumulated 
compound concentration<1% causes the combination of compounds 
that might have the potential for antiemetic activity both in single 
compound function or in synergy interaction between compounds in 
propolis or in the body. The role of these compounds needs to be 
studied further because it can have an impact on the response to the 
prevalence of nausea. However, this study did not discuss each of 
these compounds due to the low concentration of each compound, 
which would raise questions about the benefits of significant and 
effective dosages. 
Based on literature studies, propolis of Wallacetrigona incisa from 
South Sulawesi have antiemetic activity through two mechanisms: 
(1) Direct antiemetic mechanism in the form of compounds that are 
inhibitors of 5-HT4 stimuli, (2) Indirect antiemetic mechanism by 
inducing compounds in the body that capable of suppressing emetic.  
The direct antiemetic mechanism is based on the research of Eda et 
al. [7] stated that it was found that the antiemetic activity of propolis 
was caused by terpenoid and flavonoid group compounds. In 
propolis Wallacetrigona incisa from South Sulawesi was found 2 
compounds belong to the group of compounds, namely: 5-
Azulenemethanol, 1,2,3,3a, 4,5,6,7-octahydro-alpha. alpha, 3,8-
tetramethyl (terpenoids), and Methyl-α-d-glucopyranoside 
(flavonoids). Both compounds have a total concentration of 38.35% 
(36.13+2.22).  
5-Azulenemethanol, 1,2,3,3a, 4,5,6,7-octahydro-alpha. alpha, 3,8-
tetramethyl compound or better known as bulnesol compound 
which is a terpenoid group of sesquiterpene types founded in 
seasonings, spices and essential oils from tree wood, especially of 
ferula species. Bulnesol is strongly thought to provide a protective 
effect on the stomach and reduce gastrointestinal hyperactivity. This 
assumption is based on the research of Eda et al. [7] who found the 
use of terpenoid compounds in Brazilian propolis extracts that we're 
able to reduce retching in chicks given nausea agents. According to 
Ahmed et al. [13] the induction nausea agents in chicks can trigger 
emesis through the stimulus of the stomach wall through 
stimulation of 5-HT4, a natural compound terpenoid such as 
sesquiterpenes and triterpenes are thought to be able to inhibit 5-
HT4 stimuli. This mechanism is one of the mechanisms that also 
causes nausea and vomiting in humans. Apart from having a similar 
mechanism, this model is also suitable for evaluating the 
involvement of the brain in the emergence of emetic [37]. Another 
function of bulnesol along with their isomeric components, namely 
guaiol has biological activity as an antimicrobial compound [38], and 
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antifungal [39]. Bulnesol is also found in Lebanese Propolis and Chinese Propolis [40, 41]. 
 
Table 1: Active compounds of propolis W. Incisa detected using GCMS Pyrolysis 
No. Compound name RT Concentration (%) Antiemetic activity Type of mechanism 
1 2-Methoxyethyl acetate 8.510 1.16 - - 
2 8-Oxabicyclo[5.1.0]octane atau Epoxycyloheptane 12,942 2,16 - - 
3 1,2,3-Propanetriol (gliserol) 13,396 6,45 [30, 31] 2 
4 Isosorbide 15,129 1,5 - - 
5 Ethyl Ester 3-Hydroxy-Tridecanoic Acid (C13) 16,333 2,06 [14] 3 
6 2,6-Dimethoxyphenol 16,392 1,67 [32] 3 
7 Methyl-α-d-glucopyranoside (flavonoid)  16,741 1,33 [7] 1, 3 
8 1,6-Anhydro-Beta-D-Glucopyranose (Levoglucosan)  18,166 4,44 [33] 3 
9 (2S,3R)-3-Allyl-3-methylapfelsaure-4-ethylester  
(allicin)  
18,436 2,50 [34, 35] 3 
10 5-Azulenemethanol, 1,2,3,3a,4,5,6,7-octahydro-. 
alpha.,. alpha.,3,8-tetramethyl (Sesquiterpen)  
18,517 2,22 [7] 1, 3 
11 1,4,5-Trimethylnaphthalene 18,625 1,83 [36] 3 
12 Methyl. alpha.-D-glucopyranoside (flavonoid)  19,158 34,80 [7] 1, 3 
13 Dimethyl 2-hydroxy-2-methylbutane-1,4-dioatee  19,442 4,17 - - 
14 Tetradecanoic acid (Miristic acid; C14) 19,542 13,92 [14] 3 
15 Pentadecanoic acid, 14-methyl-, methyl ester  20,343 3,02 [14] 3 
16 Hexadecanoic acid  20,908 1,23 [14] 3 
 Total Concentration of Antiemetic Compound  75,47   
Details: 1) 5-HT4 stimulus inhibition 2) induction of glycerol kinase 3) hepatoprotector 
 
Methyl-α-d-glucopyranoside is a sugar/glucoside compound that 
belongs to the flavonoid group. Among all the active compounds 
detected by GC-MS pyrolysis, this glucoside compound is the main 
component of Wallacetrigona incisa propolis because it has the 
highest concentration of 36.13% (1.33%+34.80%). As the main 
component, Methyl-α-d-glucopyranoside has various biological 
activities: anti-tuberculosis [42], antibacterial [43], antifungal [44], 
antitumor [45], antivirals [46], and antiemetic [7]. Glycosides are 
strongly thought to have a protective effect on the stomach and 
reduce gastrointestinal hyperactivity. This assumption is based on 
the research of Eda et al. [7], which found flavonoid in the Brazilian 
propolis extract that was able to reduce retiching in chicks given 
nausea agents. Due to its high concentration and various biological 
activities, the presence of Methyl-α-d-glucopyranoside as the main 
composition of propolis is able to make propolis as a nutritional 
companion of ATD, which is effective in suppressing symptoms of 
emesis and in the treatment of pulmonary TB.  
The indirect antiemetic mechanism is based on the identification of 
compounds capable of inducing other compounds in the body, the 
compounds that are induced have a function in reducing and even 
eliminating the incidence of emetic. Based on this, there are two 
mechanisms that can occur, the mechanism for the formation of the 
enzyme glycerol kinase and the hepatoprotective. The mechanism for 
the formation of the glycerol kinase enzyme as a compound to prevent 
nausea and vomiting is carried out by glycerol compounds [30, 47], 
while the hepatoprotective mechanism is carried out by compounds 
that have antioxidants and anti-inflammatory activity [48, 49].  
1,2,3-Propanetriol or glycerol is a glyceride compound that makes up 
various fatty acids. The concentration of glycerol in propolis 
Wallacetrigona incisa from South Sulawesi based on GC-MS pyrolysis 
was 6.45%. Glycerol is able to prevent nausea and vomiting indirectly 
by inducing the formation of the enzyme glycerol kinase in the body. 
The activity and the amount of the glycerol kinase enzyme in the body 
is strongly influenced by the amount of ATP and glycerol available in 
the body; the relationship is a positive correlation [50]. The presence 
of glycerol and glycerol kinase in the body plays a role in the 
gluconeogenesis metabolic pathway in the liver, which will produce 
glucose [31]. This process occurs when the body is deficient in glucose, 
glycerol kinase will carry out a phosphorylation reaction against 
glycerol with a source of phosphate originating from ATP to form 
glucose-forming intermediates [31, 50]. According to Johnston et al. 
[51], the absorption of glycerol and the process of gluconeogenesis can 
be inhibited if there is damage to the liver. Thus, the hepatotoxicity 
caused by the consumption of ATD will cause a decrease in glycerol 
absorption and a decrease in the amount of the enzyme glycerol 
kinase. Deficiency of the enzyme glycerol kinase can cause nausea and 
vomiting symptoms [30, 31, 47].  
Prevention of nausea and vomiting can be done through a 
hepatoprotective mechanism. The hepatoprotector in the liver will 
prevent deficiencies in liver function as a detox and metabolic organ 
and prevent depletion of important enzymes such as cytochrome 
P450 [11]. By maintaining the liver, the symptoms of emetic caused 
by liver injury and the present of toxic compounds in the body can 
be minimized. The hepatoprotective mechanism is generally carried 
out through protective measures by phytochemical compounds that 
have antioxidant and anti-inflammatory activity [9, 49]. Antioxidant 
compounds will protect the liver from radical and toxic compounds 
produced by ATD such as ROS, n-hydrazine, acetylisoniazid and 
isonicotinic acid [22].  
2,6-dimethoxyphenol [32], 1,6-anhydro-beta-d-glucopyranose [33], 
(2S, 3R)-3-Allyl-3-methylapfelsaure-4-ethylester [34, 35], 1,4,5-
trimethylnaphthalene [36] are tested to act as antioxidant and 
showed a reduction of radical compounds 2,2-diphenyl-1-
picrylhydrazyl (DPPH). These compounds are able to reduce radical 
metabolites by binding to them by donating electrons.  
Lipid group compounds such as tridecanoic acid, tetradecanoic acid, 
pentadecanoic acid and hexadecanoic acid in propolis also have 
active functions that act as antioxidants. According to Zheng et al. 
the four fatty acids have the ability to reduce radical 2,2-diphenyl-1-
picrylhydrazyl (DPPH). The total concentration of compounds that 
act as hepatoprotectors (antioxidants) is 30.67% [14].  
The compound methyl-α-D-glucopyranoside and 5-azulenemethanol, 
1,2,3,3a, 4,5,6,7-octahydro-alpha, alpha, 3,8-tetramethyl, in addition 
to acting as antiemetics compound directly, both compounds also 
function as antioxidants and can act as hepatoprotectors by reducing 
radical metabolites [11, 52]. This is supported by the results of 
research by Kokanova-Nedialkova et al. [53] and Vinholes et al. [54] 
which showed that these two compounds had a strong ability to 
reduce radical 2,2-diphenyl-1-picrylhydrazyl (DPPH).  
Based on the concentration and mechanism of compounds that act 
as antiemetic, the percentage of antiemetic compounds either 
through direct and indirect mechanisms reaches 75.47% 
(38.35%+6.45%+30.67%). This concentration is very large, even 
reaching 3⁄4 of the total concentration of propolis. Based on the 
concentration of these antiemetic compounds, the propolis of 
Wallacetrigona incisa from South Sulawesi is very potential as an 
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antiemetic product, supported by the effect of propolis in reducing 
the prevalence of emetic induced by ATD in pulmonary TB patients. 
CONCLUSION 
Propolis of Wallacetrigona incisa species from South Sulawesi has 
antiemetic activity and is able to reduce the prevalence of emetic 
induced by ATD consumption in pulmonary TB patients. Propolis 
concentration 30% showed better antiemetic activity than propolis 
concentration 6%. There are antiemetic compounds with a total 
concentration of 75.47%. The antiemetic mechanism occurs through 
three mechanisms: (1) Direct antiemetic mechanism in the form of 
inhibition of the 5-HT4 stimulus which can trigger nausea and 
vomiting, (2) Indirect antiemetic mechanism by inducing the 
formation of the glycerol kinase enzyme which can suppress nausea 
and vomiting, (3) Indirect antiemetic mechanism by protecting the 
liver as a detoxifying organ for toxic compounds so that nausea can 
be avoided. 
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